DMSI Stock Chart & Stats
$0.01
<$0.01(1200.00%)
At close: 4:00 PM EST
$0.01
<$0.01(1200.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume765.00
Average Volume (3M)0.00
Market Cap
$831.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding63,909,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DMSI FAQ
What was Dermisonics Inc’s price range in the past 12 months?
Dermisonics Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Dermisonics Inc’s market cap?
Dermisonics Inc’s market cap is $831.00.
When is Dermisonics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Dermisonics Inc’s earnings last quarter?
Currently, no data Available
Is Dermisonics Inc overvalued?
According to Wall Street analysts Dermisonics Inc’s price is currently Overvalued.
Does Dermisonics Inc pay dividends?
Dermisonics Inc does not currently pay dividends.
What is Dermisonics Inc’s EPS estimate?
Dermisonics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dermisonics Inc have?
Dermisonics Inc has 63,909,000 shares outstanding.
What happened to Dermisonics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Dermisonics Inc?
Currently, no hedge funds are holding shares in DMSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dermisonics Inc
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large molecular weight drugs, like Insulin, directly into the circulatory system. The firm was originally incorporated as Second Stage Ventures, Inc. before adopting its current name, Dermisonics, Inc., in October 2004. Founded in 2000, the company maintains its principal offices in Irvine, California.